Enabling AMR-related Clinical Trials in India: Network Exploratory Workshop

On 25–26 November 2019, the Indian Council of Medical Research (ICMR) and the Global Antibiotic Research and Development Partnership (GARDP) organized a two-day workshop to map out the opportunities, challenges and practicalities of carrying out clinical trials of new antibiotics in India. Held at the ICMR headquarters in New Delhi, India, the workshop brought together […]

STD Awareness Week: Uniting against drug-resistant gonorrhoea

On STD Awareness Week (12-18 April), we’re celebrating advances made against gonorrhoea, while casting a light on a harsh truth. Despite being preventable and treatable, gonorrhoea is on the rise. More partnerships are needed, and must move faster, to support research, development and access to new treatments for gonorrhoea and other curable STIs, for every person who needs them.

Message on passing of Martin Khor

We and our colleagues and at GARDP and DNDi are deeply saddened by the passing of Martin Khor, a friend and trusted advisor to colleagues and partners around the world working to advance medical innovation and access to treatment for vulnerable and neglected people.

GARDP completes recruitment in neonatal sepsis study

The Global Antibiotic Research and Development Partnership (GARDP) announced today that with their partners St George’s University of London and the Paediatric Infectious Disease Network (Penta), they have completed recruitment for their neonatal sepsis observational study. The observational study has recruited more than 3,200 newborns across 19 sites in 11 countries. Reaching this important milestone […]

We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.